These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

425 related items for PubMed ID: 17201089

  • 21. Incidence and outcome of primary Epstein-Barr virus infection and lymphoproliferative disease in pediatric heart transplant recipients.
    Zangwill SD, Hsu DT, Kichuk MR, Garvin JH, Stolar CJ, Haddad J, Stylianos S, Michler RE, Chadburn A, Knowles DM, Addonizio LJ.
    J Heart Lung Transplant; 1998 Dec; 17(12):1161-6. PubMed ID: 9883755
    [Abstract] [Full Text] [Related]

  • 22. Quantification of a low cellular immune response to aid in identification of pediatric liver transplant recipients at high-risk for EBV infection.
    Lee TC, Goss JA, Rooney CM, Heslop HE, Barshes NR, Caldwell YM, Gee AP, Scott JD, Savoldo B.
    Clin Transplant; 2006 Dec; 20(6):689-94. PubMed ID: 17100717
    [Abstract] [Full Text] [Related]

  • 23. Presentation and early detection of post-transplant lymphoproliferative disorder after solid organ transplantation.
    Bakker NA, van Imhoff GW, Verschuuren EA, van Son WJ.
    Transpl Int; 2007 Mar; 20(3):207-18. PubMed ID: 17291214
    [Abstract] [Full Text] [Related]

  • 24. The value of prospective monitoring of Epstein-Barr virus DNA in blood samples of pediatric liver transplant recipients.
    Scheenstra R, Verschuuren EA, de Haan A, Slooff MJ, The TH, Bijleveld CM, Verkade HJ.
    Transpl Infect Dis; 2004 Mar; 6(1):15-22. PubMed ID: 15225222
    [Abstract] [Full Text] [Related]

  • 25. Comparison of serum and whole blood levels of cytomegalovirus and Epstein-Barr virus DNA.
    Kullberg-Lindh C, Olofsson S, Brune M, Lindh M.
    Transpl Infect Dis; 2008 Oct; 10(5):308-15. PubMed ID: 18466193
    [Abstract] [Full Text] [Related]

  • 26. Decreasing the Epstein-Barr virus load by adjusting the FK506 blood level.
    Orii T, Ohkohchi N, Satomi S, Hoshino Y, Kimura H.
    Transpl Int; 2002 Nov; 15(11):529-34. PubMed ID: 12461655
    [Abstract] [Full Text] [Related]

  • 27. Soluble CD30: a serum marker for Epstein-Barr virus-associated lymphoproliferative diseases.
    Haque T, Chaggar T, Schafers J, Atkinson C, McAulay KA, Crawford DH.
    J Med Virol; 2011 Feb; 83(2):311-6. PubMed ID: 21181928
    [Abstract] [Full Text] [Related]

  • 28. Comparison of immortalization assay and polymerase chain reaction detection of Epstein-Barr virus in pediatric transplant recipients and control samples.
    Salimi B, Alonso EM, Cohn RA, Mendley SR, Katz BZ.
    Pediatr Pathol Mol Med; 2002 Feb; 21(4):433-43. PubMed ID: 12092707
    [Abstract] [Full Text] [Related]

  • 29. [Evaluation of PCR results in the diagnosis of Epstein-Barr virus infections].
    Karadağ Geçgel S, Ersoy A, Sevinir BB, Sınırtaş M, Göral G.
    Mikrobiyol Bul; 2012 Oct; 46(4):594-606. PubMed ID: 23188573
    [Abstract] [Full Text] [Related]

  • 30. Detection of specific lytic and latent transcripts can help to predict the status of Epstein-Barr virus infection in transplant recipients with high virus load.
    Zawilinska B, Kosinska A, Lenart M, Kopec J, Piatkowska-Jakubas B, Skotnicki A, Kosz-Vnenchak M.
    Acta Biochim Pol; 2008 Oct; 55(4):693-9. PubMed ID: 19015775
    [Abstract] [Full Text] [Related]

  • 31. Complete immunosuppressive withdrawal as a uniform approach to post-transplant lymphoproliferative disease in pediatric liver transplantation.
    Hurwitz M, Desai DM, Cox KL, Berquist WE, Esquivel CO, Millan MT.
    Pediatr Transplant; 2004 Jun; 8(3):267-72. PubMed ID: 15176965
    [Abstract] [Full Text] [Related]

  • 32. Monitoring of EBV-DNAemia by quantitative real-time PCR after adult liver transplantation.
    Loginov R, Aalto S, Piiparinen H, Halme L, Arola J, Hedman K, Höckerstedt K, Lautenschlager I.
    J Clin Virol; 2006 Oct; 37(2):104-8. PubMed ID: 16931140
    [Abstract] [Full Text] [Related]

  • 33. Epstein-Barr viral load in whole blood of adults with posttransplant lymphoproliferative disorder after solid organ transplantation does not correlate with clinical course.
    Oertel S, Trappe RU, Zeidler K, Babel N, Reinke P, Hummel M, Jonas S, Papp-Vary M, Subklewe M, Dörken B, Riess H, Gärtner B.
    Ann Hematol; 2006 Jul; 85(7):478-84. PubMed ID: 16586109
    [Abstract] [Full Text] [Related]

  • 34. Diagnosis and treatment of post-transplantation lymphoproliferative disorder in pediatric heart transplant patients.
    Schubert S, Abdul-Khaliq H, Lehmkuhl HB, Yegitbasi M, Reinke P, Kebelmann-Betzig C, Hauptmann K, Gross-Wieltsch U, Hetzer R, Berger F.
    Pediatr Transplant; 2009 Feb; 13(1):54-62. PubMed ID: 18518912
    [Abstract] [Full Text] [Related]

  • 35. Normalized quantification by real-time PCR of Epstein-Barr virus load in patients at risk for posttransplant lymphoproliferative disorders.
    Jabs WJ, Hennig H, Kittel M, Pethig K, Smets F, Bucsky P, Kirchner H, Wagner HJ.
    J Clin Microbiol; 2001 Feb; 39(2):564-9. PubMed ID: 11158107
    [Abstract] [Full Text] [Related]

  • 36. Significance of detecting Epstein-Barr-specific sequences in the peripheral blood of asymptomatic pediatric liver transplant recipients.
    Krieger NR, Martinez OM, Krams SM, Cox K, So S, Esquivel CO.
    Liver Transpl; 2000 Jan; 6(1):62-6. PubMed ID: 10648579
    [Abstract] [Full Text] [Related]

  • 37. Serum Epstein-Barr virus DNA load in primary Epstein-Barr virus infection.
    Bauer CC, Aberle SW, Popow-Kraupp T, Kapitan M, Hofmann H, Puchhammer-Stöckl E.
    J Med Virol; 2005 Jan; 75(1):54-8. PubMed ID: 15543583
    [Abstract] [Full Text] [Related]

  • 38. Associations of serum EBV DNA and gammopathy with post-transplant lymphoproliferative disease.
    Rosselet A, Vu DH, Meylan P, Chaubert AS, Schapira M, Pascual M, Aubert V, Tissot JD, Duchosal MA.
    Clin Transplant; 2009 Jan; 23(1):74-82. PubMed ID: 19200218
    [Abstract] [Full Text] [Related]

  • 39. Epstein-Barr virus load in transplant patients: Early detection of post-transplant lymphoproliferative disorders.
    Fellner MD, Durand KA, Solernou V, Bosaleh A, Balbarrey Z, García de Dávila MT, Rodríguez M, Irazu L, Alonio LV, Picconi MA.
    Rev Argent Microbiol; 2016 Jan; 48(2):110-8. PubMed ID: 27157146
    [Abstract] [Full Text] [Related]

  • 40. Prospective Epstein-Barr virus-related post-transplant lymphoproliferative disorder prevention program in pediatric allogeneic hematopoietic stem cell transplant: virological monitoring and first-line treatment.
    Chiereghin A, Prete A, Belotti T, Gibertoni D, Piccirilli G, Gabrielli L, Pession A, Lazzarotto T.
    Transpl Infect Dis; 2016 Feb; 18(1):44-54. PubMed ID: 26574232
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.